In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models |
| |
Affiliation: | 1. Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China;2. Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China;3. Yunnan University of Traditional Chinese Medicine, Kunming 650500, China;4. Shanghai Institute of Planned Parenthood Research, National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, Shanghai 200032, China |
| |
Abstract: | The purpose of this study is to evaluate the in vivo retention capabilities of poloxamer-based in situ hydrogels for vaginal application with nonoxinol-9 as the model drug. Two in situ hydrogel formulations, which contained 18% poloxamer 407 plus 1% poloxamer 188 (GEL1, relative hydrophobic) or 6% poloxamer 188 (GEL2, relative hydrophilic), were compared with respect to the rheological properties, in vitro hydrogel erosion and drug release. The vaginal retention capabilities of these hydrogel formulations were further determined in two small animal models, including drug quantitation of vaginal rinsing fluid in mice and isotope tracing with 99mTc in rats. The two formulations exhibited similar phase transition temperatures ranging from 27 to 32 °C. Increasing the content of poloxamer 188 resulted in higher rheological moduli under body temperature, but slightly accelerated hydrogel erosion and drug release. When compared in vivo, GEL1 was eliminated significantly slower in rat vagina than GEL2, while the vaginal retention of these two hydrogel formulations behaved similarly in mice. In conclusion, increases in the hydrophilic content of formulations led to faster hydrogel erosion, drug release and intravaginal elimination. Rats appear to be a better animal model than mice to evaluate the in situ hydrogel for vaginal application. |
| |
Keywords: | AUC" },{" #name" :" keyword" ," $" :{" id" :" key0010" }," $$" :[{" #name" :" text" ," _" :" area under curve EO" },{" #name" :" keyword" ," $" :{" id" :" key0020" }," $$" :[{" #name" :" text" ," _" :" hydrophilic ethylene oxide F127" },{" #name" :" keyword" ," $" :{" id" :" key0030" }," $$" :[{" #name" :" text" ," _" :" Poloxamer 407 F68" },{" #name" :" keyword" ," $" :{" id" :" key0040" }," $$" :[{" #name" :" text" ," _" :" poloxamer 188 GEL1" },{" #name" :" keyword" ," $" :{" id" :" key0050" }," $$" :[{" #name" :" text" ," $$" :[{" #name" :" __text__" ," _" :" 1% poloxamer 188" },{" #name" :" hsp" ," $" :{" sp" :" 0.25" }},{" #name" :" __text__" ," _" :" +" },{" #name" :" hsp" ," $" :{" sp" :" 0.25" }},{" #name" :" __text__" ," _" :" 18% poloxamer 407 GEL2" },{" #name" :" keyword" ," $" :{" id" :" key0060" }," $$" :[{" #name" :" text" ," $$" :[{" #name" :" __text__" ," _" :" 6% poloxamer 188" },{" #name" :" hsp" ," $" :{" sp" :" 0.25" }},{" #name" :" __text__" ," _" :" +" },{" #name" :" hsp" ," $" :{" sp" :" 0.25" }},{" #name" :" __text__" ," _" :" 18% poloxamer 407 HLB" },{" #name" :" keyword" ," $" :{" id" :" key0070" }," $$" :[{" #name" :" text" ," _" :" hydrophile--lipophile balance ICR" },{" #name" :" keyword" ," $" :{" id" :" key0080" }," $$" :[{" #name" :" text" ," _" :" Institute of Cancer Research MRT" },{" #name" :" keyword" ," $" :{" id" :" key0090" }," $$" :[{" #name" :" text" ," _" :" mean residence time MW" },{" #name" :" keyword" ," $" :{" id" :" key0100" }," $$" :[{" #name" :" text" ," _" :" molecular weight N-9" },{" #name" :" keyword" ," $" :{" id" :" key0110" }," $$" :[{" #name" :" text" ," _" :" Nonoxynol-9 PEO-PPO-PEO" },{" #name" :" keyword" ," $" :{" id" :" key0120" }," $$" :[{" #name" :" text" ," $$" :[{" #name" :" __text__" ," _" :" poly(ethylene oxide)" },{" #name" :" inf" ," $" :{" loc" :" post" }," $$" :[{" #name" :" italic" ," _" :" a PO" },{" #name" :" keyword" ," $" :{" id" :" key0130" }," $$" :[{" #name" :" text" ," _" :" hydrophobic propylene oxide RP-HPLC" },{" #name" :" keyword" ," $" :{" id" :" key0140" }," $$" :[{" #name" :" text" ," _" :" reverse-phase high performance liquid chromatography SVF" },{" #name" :" keyword" ," $" :{" id" :" key0150" }," $$" :[{" #name" :" text" ," _" :" simulated vaginal fluid Vaginal administration Poloxamer Thermosensitive hydrogel Retention Nonoxinol-9 |
本文献已被 ScienceDirect 等数据库收录! |
|